In a bid to make medicines more affordable, the NPPA has slashed retail prices of 35 essential drug formulations, including those for heart, diabetes, and mental health. The revised prices apply to tablets, suspensions, drops, and injections. Retailers must display updated prices, and violations may attract penalties under DPCO and Essential Commodities Act.